WEBER LUTZ has a total of 13 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States, Germany and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets chemical engineering, organic fine chemistry and pharmaceuticals are STEAG MICROPARTS GMBH, MULTI TECHNOLOGY INC and RAPID MEDICAL DIAGNOSTICS CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | Germany | 1 | |
#3 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Chemical engineering | |
#2 | Organic fine chemistry | |
#3 | Pharmaceuticals | |
#4 | Mechanical elements | |
#5 | Machines | |
#6 | Engines, pumps and turbines | |
#7 | Computer technology | |
#8 | Measurement | |
#9 | Packaging and shipping |
# | Name | Total Patents |
---|---|---|
#1 | Weber Lutz | 13 |
#2 | Neumeier Michel | 1 |
#3 | Khazak Vladimir | 1 |
#4 | Bohme Timo | 1 |
#5 | Ross Guenther F | 1 |
#6 | Kalinski Cotic | 1 |
#7 | Burdack Christoph | 1 |
Publication | Filing date | Title |
---|---|---|
US2011055233A1 | Methods, computer systems, software and storage media for handling many data elements for search and annotation | |
US2008176860A1 | Pyridin-2-one compounds | |
WO2006097323A1 | TETRAHYDRO-ISOQUINOLIN-l-ONES FOR THE TREATMENT OF CANCER | |
DE102005012681A1 | New 1,5-dihydro-pyrrol-2-one compounds are HDM2 inhibitors, useful for treating e.g. stroke, heart infarct, ischemia, multiple sclerosis, Alzheimer's disease, degenerative disease, viral infection and cancer |